Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis
- PMID: 33770176
- PMCID: PMC8083649
- DOI: 10.1093/infdis/jiab163
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis
Abstract
Invasive pulmonary aspergillosis (IPA) is increasingly recognized as a life-threatening superinfection of severe respiratory viral infections, such as influenza. The pandemic of Coronavirus Disease 2019 (COVID-19) due to emerging SARS-CoV-2 rose concern about the eventuality of IPA complicating COVID-19 in intensive care unit patients. A variable incidence of such complication has been reported, which can be partly attributed to differences in diagnostic strategy and IPA definitions, and possibly local environmental/epidemiological factors. In this article, we discuss the similarities and differences between influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA). Compared to IAPA, the majority of CAPA cases have been classified as putative rather than proven/probable IPA. Distinct physiopathology of influenza and COVID-19 may explain these discrepancies. Whether CAPA represents a distinct entity is still debatable and many questions remain unanswered, such as its actual incidence, the predisposing role of corticosteroids or immunomodulatory drugs, and the indications for antifungal therapy.
Keywords: Aspergillus fumigates; SARS-CoV-2; acute respiratory distress syndrome; corticosteroids; flu; intensive care unit; mechanical ventilation; pneumonia.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Similar articles
-
Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.Lancet Respir Med. 2022 Dec;10(12):1147-1159. doi: 10.1016/S2213-2600(22)00259-4. Epub 2022 Aug 24. Lancet Respir Med. 2022. PMID: 36029799 Free PMC article.
-
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.Intensive Care Med. 2020 Aug;46(8):1524-1535. doi: 10.1007/s00134-020-06091-6. Epub 2020 Jun 22. Intensive Care Med. 2020. PMID: 32572532 Free PMC article.
-
Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.Eur J Clin Microbiol Infect Dis. 2024 Apr;43(4):683-692. doi: 10.1007/s10096-024-04772-4. Epub 2024 Feb 7. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38326545
-
Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices.APMIS. 2023 Nov;131(11):654-667. doi: 10.1111/apm.13316. Epub 2023 Apr 25. APMIS. 2023. PMID: 37022291 Review.
-
Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients.Lancet Respir Med. 2024 Sep;12(9):728-742. doi: 10.1016/S2213-2600(24)00151-6. Epub 2024 Jul 15. Lancet Respir Med. 2024. PMID: 39025089 Review.
Cited by
-
Immunity to fungi in the lung.Semin Immunol. 2023 Mar;66:101728. doi: 10.1016/j.smim.2023.101728. Epub 2023 Feb 24. Semin Immunol. 2023. PMID: 36841146 Free PMC article. Review.
-
Invasive Pulmonary Aspergillosis: Not Only a Disease Affecting Immunosuppressed Patients.Diagnostics (Basel). 2023 Jan 26;13(3):440. doi: 10.3390/diagnostics13030440. Diagnostics (Basel). 2023. PMID: 36766545 Free PMC article.
-
Covid-19 and Mucormycosis Superinfection: Prospective, Obsevational Study in a Single Center.Ann Indian Acad Neurol. 2022 May-Jun;25(3):441-448. doi: 10.4103/aian.aian_1097_21. Epub 2022 Jun 9. Ann Indian Acad Neurol. 2022. PMID: 35936631 Free PMC article.
-
Missed Opportunities for Antifungal Stewardship during the COVID-19 Era.Antibiotics (Basel). 2023 Aug 23;12(9):1352. doi: 10.3390/antibiotics12091352. Antibiotics (Basel). 2023. PMID: 37760649 Free PMC article.
-
Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements.Ann Intensive Care. 2021 Sep 15;11(1):136. doi: 10.1186/s13613-021-00923-4. Ann Intensive Care. 2021. PMID: 34524562 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous